RB

Renu Bhagavatprasad

Director Designated Partner DIN 07537621
DIN 07537621 First appointment Jun 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Renu Bhagavatprasad

Data last updated:

Renu Bhagavatprasad was a Designated Partner at Cubane Pharmaceuticals Llp (2018) and Designated Partner at Prasad Eateries Llp (from 2016). The companies operate in Pharma.

DIN 07537621
Primary Designation Designated Partner
Industry Pharma
First Appointment 28 Jun 2016
Oldest Company Age 10 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner14 Jun 20182018Active
Designated Partner28 Jun 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Prasad Eateries Llp
Cubane Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Renu Bhagavatprasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Bhagavatprasad

Renu Bhagavatprasad was first appointed on 28 Jun 2016 as Designated Partner at Prasad Eateries Llp. The most recent appointment on record is 14 Jun 2018 at Cubane Pharmaceuticals Llp.

Renu Bhagavatprasad held 2 earlier board appointments: Cubane Pharmaceuticals Llp (Designated Partner, 14 Jun 2018 to 01 Oct 2018); Prasad Eateries Llp (Designated Partner, from 28 Jun 2016).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available